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Abstract
Introduction Actinomycetes produce the majority of the
antibiotics currently in clinical use. The efficiency of
antibiotic production is affected by multiple factors such as
nutrients, pH, temperature and growth phase. Finding the
optimal harvesting time is crucial for successful isolation
of the desired bioactive metabolites from actinomycetes,
but for this conventional chemical analysis has limitations
due to the metabolic complexity.
Objectives This study explores the utility of NMR-based
metabolomics for (1) optimizing fermentation time for the
production of known and/or unknown bioactive com-
pounds produced by actinomycetes; (2) elucidating the
biosynthetic pathway for microbial natural products; and
(3) facilitating the biotransformation of nature-abundant
chemicals.
Method The aqueous culture broth of actinomycete
Streptomyces sp. MBT76 was harvested every 24 h for
5 days and each broth was extracted by ethyl acetate. The
extracts were analyzed by 1H NMR spectroscopy and the
data were compared with principal component analysis
(PCA) and orthogonal projection to latent structures
(OPLS) analysis. Antimicrobial test were performed by
agar diffusion assay.
Results The secondary metabolites production by Strep-
tomyces sp. MBT76 was growth phase-dependent. Iso-
coumarins (1–9), undecylprodiginine (10), streptorubin B
(11), 1H-pyrrole-2-carboxamide (12), acetyltryptamine
(13), and fervenulin (14) were identified, and their optimal
production time was determined in crude extracts without
tedious chromatographic fractionation. Of these com-
pounds, 5,6,7,8-tetramethoxyl-3-methyl-isocoumarin (9) is
as a novel compound, which was most likely synthesized
by a type I iterative polyketide synthase (PKS) encoded by
the icm gene cluster. Multivariate data analysis of the 1H
NMR spectra showed that acetyltryptamine (13) and tri-
methoxylated isocoumarins (7 and 8) were the major
determinants of antibiotic activity during later time points.
The methoxylation was exploited to allow bioconversion of
exogenously added genistein into a suite of methoxylated
isoflavones (15–18). Methoxylation increased the antimi-
crobial efficacy of isocoumarins, but decreased that of the
isoflavones.
Conclusion Our results show the applicability of NMR-
based metabolic profiling to streamline microbial bio-
transformation and to determine the optimal harvesting
time of actinomycetes for antibiotic production.
Keywords Streptomyces  Antibiotics  Growth phase-
dependence  NMR-based metabolomics 
Biotransformation
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1 Introduction
The alarming increase of pathogen resistance underlines
the urgent need for new antibiotics (WHO 2014). As pro-
ducers of two-thirds of all known antibiotics and of many
other bioactive compounds, actinomycetes are a rich source
of clinical drugs, with the majority produced by members
of the genus Streptomyces (Barka et al. 2016; Be´rdy 2005).
A problem is the high frequency of re-discovery of known
compounds that has frustrated high-throughput (HT)
screening regimes in the past decennia (Cooper and Shlaes
2011; Payne et al. 2007). Sequencing of the genomes of
actinomycetes revealed that the potential of even the best-
studied model organisms as producers of natural products
have been grossly underestimated (Bentley et al. 2002;
Cruz-Morales et al. 2013; Ikeda et al. 2003). However,
many antibiotic biosynthetic gene clusters are poorly
expressed under routine laboratory conditions. A new drug-
discovery pipeline is rapidly gaining momentum, which is
combining fluctuation of the (cryptic) antibiotics produc-
tion with metabolic profiling-based identification of the
bioactivity of interest (Scherlach and Hertweck 2009; Wu
et al. 2015b; Zhu et al. 2014a).
In actinomycetes, the onset of antibiotic production
typically coincides with the transition from vegetative to
aerial growth in solid-grown cultures, which corresponds
roughly to the onset of stationary phase in liquid-grown
cultures (Bibb 2005; van Wezel and McDowall 2011). It is
therefore very important to closely monitor the metabolic
changes during the entire fermentation time, so as to
optimize the fermentation for production of the bioactive
molecules of interest. Conventional analytical methods,
e.g. HPLC–UV, are often used to monitor the production of
molecules but fail to provide structural information and the
detection of analytes tends to be demanding on chro-
mophores. To capture all the molecular features in a
microbial mixture without prior information, techniques
with a broader analytical capacity should be employed.
Moreover, to take a snapshot of multiple cellular processes
at for example any given time-point of a growth curve of a
producing microorganism, a robust analytical platform is
needed, which should be rapid, reproducible, stable in time,
and simple in sample preparation (Kim et al. 2011). Proton
nuclear magnetic resonance (1H NMR) spectroscopy pro-
vides both qualitative (chemical shift and splitting pattern)
and quantifiable (integrative area) peaks for structure elu-
cidation (sometimes aided by 2D NMR), allowing tracing
of metabolic changes over time by visual comparison of the
metabolomes harvested at several time-points (Novoa-
Carballal et al. 2011). Subtle metabolic differences could
be further highlighted by unbiased statistical filtering of the
1H NMR spectra, such as chemometric methods, principle
component analysis (PCA), partial least squares discrimi-
nant analysis (PLS-DA), etcetera.
Actinomycetes do not only producing a plethora of
natural products, but they can also efficiently perform
metabolic conversions on molecules with a range of
physicochemical properties (Wu et al. 2015d). Deciphering
the metabolic tailoring reactions of natural products pro-
duced by a certain producing strain over time, such as
glycosylation, hydroxylation, O-methylation, or prenyla-
tion (Medema et al. 2015), will provide insights into the
optimal time of providing starter molecules in biotrans-
formation experiments, since many enzymes show signifi-
cant promiscuity in terms of substrate specificity (Schwab
2003).
In this study, NMR-based metabolomics was used to
determine the variation in metabolites produced by Strep-
tomyces sp. MBT76 at five different time-points and cor-
related these to the observed bioactivity using multivariate
data analysis (MVDA). Aided by UPLC-ToF–MS analysis,
various bioactive molecules (1–14) including a new tetra-
methoxylated isocoumarin (9), were thus identified in the
culture broth. Biotransformation of the isoflavone genistein
by MBT76 led to a group of methoxylated derivatives
15–18. Methoxylation increased the efficacy of iso-
coumarins against both Gram-positive and Gram-negative
bacteria, while conversely, methoxylation decreased the
antimicrobial efficacy of isoflavones.
2 Materials and methods
2.1 Culture media and condition
Streptomyces sp. MBT76 was obtained from the culture
collection of Molecular Biotechnology, IBL, Leiden
University. Liquid Minimal Medium (NMMP) (Hodgson
1982) was used as medium for fermentation. Fully sup-
plemented NMMP contained per liter 2 g (NH4)2SO4, 5 g
casaminoacids, 0.6 g MgSO4.7H2O, 1 ml minor elements
solution, 15 mM Na?–K? phosphate buffer pH 6.8, 0.5 %
mannitol, 1 % glycerol and 8 g peptone. Spores of Strep-
tomyces sp. MBT76 were inoculated into 50 ml of culture
medium, and cultures were incubated at 30 C with con-
tinuous shaking at 220 rpm.
2.2 Isolation of bioactive compounds
Streptomyces sp. MBT76 mycelia were removed by cen-
trifugation at 4,5009g for 10 min. The spent media (cul-
ture supernatant) was extracted twice with 20 ml of ethyl
acetate. The organic phase was washed with 30 ml of
distilled water and dried with 5 g of anhydrous Na2SO4.
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Finally, the ethyl acetate solvent was evaporated under
vacuum at 40 C and the resultant dried material was dis-
solved in 1.5*2.0 ml of ethyl acetate in a microtube
(Eppendorf type-5415C, Hamburg, Germany). The crude
extract was evaporated under room temperature to remove
organic solvent, and subsequently dipped into liquid
nitrogen and lyophilized by freeze drier (Edwards Ltd.,
Crawley, UK). The obtained residue was independently
dissolved in methanol-d4 for
1H NMR analysis (see below).
All experiments were conducted in five replicates.
After 1H NMR measurement, the five 96 h samples were
combined and dissolved in methanol (50 ml), which was
defatted twice with 20 ml of n-hexane. The resulting crude
extract was directly separated by semi-preparative HPLC,
which was performed with a Agilent 1200 series HPLC
apparatus (Agilent technologies Inc, Santa Clara, CA,
USA) equipped with a reversed-phase C18 column (Phe-
nomenex Luna C18 (2) 100 A˚ 5 micron 250 9 10 mm,
Torrance, CA, USA). The separation was eluted with a
gradient of acetonitrile in water from 20 % to 70 % in
50 min at 2 ml/min flow rate, to obtain compounds 1
(tR = 31.52 min, 1.14 mg), 3 (tR = 35.75 min, 1.62 mg),
7 (tR = 38.34 min, 0.34 mg), 8 (tR = 39.50 min,
0.28 mg).
2.3 NMR measurement and data analysis
NMR sample preparation and measurements were done
according to our previously published protocol (Kim
et al. 2010). Briefly, 0.5 ml of methanol-d4 was added to
the freeze-dried sample. Subsequently, the mixture was
vortexed for 10 s and sonicated for 20 min at 42 kHz
using an Ultrasonicator 5510E-MT (Branson, Danbury,
CT, USA), followed by centrifugation at 13,0009g at
room temperature for 5 min. The supernatant (0.3 ml)
was transferred to a 5 mm micro NMR tube and ana-
lyzed. The 1H NMR spectra were recorded at 25 C on a
600 MHz Bruker DMX-600 spectrometer (Bruker,
Karlsruhe, Germany) operating at a proton NMR fre-
quency of 600.13 MHz. Deuterated methanol was used
as the internal lock. Each 1H NMR spectrum consisted of
128 scans using the following parameters: 0.16 Hz/point,
pulse width (PW) = 30 (11.3 ls) and relaxation delay
(RD) = 1.5 s. Free induction decays (FIDs) were Four-
ier transformed with a line broadening (LB) = 0.3 Hz.
The resulting spectra were manually phased and baseline
corrected, and calibrated to residual methanol-d4 at
3.30 ppm, using XWIN NMR (version 3.5, Bruker). The
1H NMR data files were processed as described by Kim
et al. (2010). The AMIX software (Bruker Biospin
GmbH) was used to reduce the 1H NMR spectra to an
ASCII file, with total intensity scaling. Bucketing or
binning was performed and the spectral data were
reduced to included regions of equal width (0.04 ppm)
equivalent to the region of d 0.30–10.00. The regions of
d 4.85–4.95 and 3.25–3.35 were removed in the analysis
because of the remaining signal of solvents of HDO and
CD3OD, respectively. Principal component analysis
(PCA) and orthogonal projection to latent structures
(OPLS) based on Pareto scaling were performed with the
SIMCA-P? software (version 13.0, Umetrics, Umea˚,
Sweden).
2.4 UPLC-ToF–MS analysis
UPLC-ToF–MS analyses were performed on an UPLC
system (Ultimate 3000, ThermoScientific, Germany) cou-
pled to an ESI-llQ-ToF spectrometer (micrOToF-QII,
Bruker Daltonics, Germany) in the positive mode. The
chromatographic separation was done using a Kinetex C18
UPLC 2.6 lm particle size column 150 9 2.0 mm (Phe-
nomenex, Torrance, CA, USA) at a flow rate of 0.3 ml/min
and a column temperature of 30 C. Samples (3 ll) were
eluted using a gradient of solvent A (water) and B (ace-
tonitrile), both with 0.1 % formic acid (v/v). The initial
percentage of B was 5 %, which was linearly increased to
90 % in 19.5 min, followed by a 2 min isocratic period
and, then re-equilibrated with original conditions in 2 min.
Nitrogen was used as drying and nebulizing gas. The gas
flow was set at 10.0 l/min at 250 C and the nebulizer
pressure was 2.0 bar. The MS data were acquired over m/z
range of 100–1000. The capillary voltage was 3.5 kV. For
internal calibration, a 10 mM solution of sodium formate
(Fluka, Steinheim, Germany) was infused. Formic acid,
water and acetonitrile were LCMS grade, Optima (Fisher
Scientific, Waltham, MA,USA).
2.5 Biotransformation
Substrates (10 mg) dissolved in 200 ll DMSO were fed to
2-day old Streptomyces sp. MBT76 culture broth. This
biotransformation period lasted for another 3 days. The
control experiment included both negative control of
feeding 200 ll DMSO solvent to MBT76, and positive
control of 10 mg substrates dissolved in 200 ll DMSO
added to sterile culture media. Each experiment was done
in triplicate. The method used to harvest the biotransfor-
mation products was as described for the metabolomics
study.
To isolate the biotransformation products of genistein
(Sigma), the combined mixture in 50 ml methanol was first
defatted twice with 20 ml of n-hexane, which was subse-
quently fractionated by Sephadex LH-20 chromatography
(GE Healthcare Life Sciences, Eindhoven, The Nether-
lands) eluting with methanol, to give seven fractions fr1–7.
These fractions were subjected to NMR profiling to discard
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fr1–3, and fr6 that gave no isoflavone signals. Fr7 was
purified by silica gel (pore size 60 A˚, 70–230 mesh, St.
Louis, MO, USA) to yield compound 15 (0.7 mg). Fr4 was
separated by preparative TLC on a silica gel plate (Si60,
Merck, Darmstadt, Germany), migrated with solvent sys-
tem of CHCl3-MeOH (20:3) to give pure compound 16
(0.5 mg) and semi-pure compound 18 (0.2 mg). Fr5 was
purified by preparative TLC to give pure compound 17
(0.3 mg) using the same TLC conditions.
2.6 Antimicrobial activity of the isocoumarins
and isoflavones
Antimicrobial test were performed by agar diffusion
assay, against the Gram-positive indicator strain Bacillus
subtilis 168 and the Gram-negative Escherichia coli K12,
as we previously described (Wu et al. 2015c). The
respective compounds were dissolved in methanol (2 mg/
ml), and 20 ll of the solution was applied on a paper disc
(6 mm diameter). The discs were then placed onto an agar
plate containing a soft agar overlay with either Bacillus
subtilis 168 or Escherichia coli K12. After incubation at
37 C for 18 h, growth inhibition zones (in mm) were
monitored visually as a measure of the antimicrobial
activity.
2.7 Genome sequencing, assembly, and annotation
Genome sequencing and annotation was done as described
previously (Girard et al. 2014). Illumina/Solexa sequencing
on Genome Analyzer IIx and sequencing on PacBio RS
were outsourced to BaseClear BV (Leiden, The Nether-
lands). 100-nt paired-end reads were obtained and the
quality of the short reads verified using FastQC (http://
www.bioinformatics.bbsrc.ac.uk/projects/fastqc/). Depend-
ing on quality, reads were trimmed to various lengths at
both ends. Processed raw reads were subsequently used as
input for the Velvet assembly algorithm. Genomes were
annotated using the RAST server with default options.
Contigs were also annotated using GeneMark.hmm for
ORF prediction, BLASTP for putative function prediction
and HMMER for protein-domain prediction, manually
inspected for some and visualized using Artemis. Strepto-
myces sp. MBT76 was subjected to Illumina/Solexa whole
genomic sequencing, and the genome was assembled in 13
contigs, with a total genome size of 8.64 Mb. In total 7974
coding sequences (CDS) were predicted. Analysis of the
contigs by AntiSMASH (Blin et al. 2013) presented a
possible 55 putative biosynthetic gene clusters (BGCs)
specifying secondary metabolites. The genome has been
deposited at GenBank under the accession LNBE00000
000.
3 Results and discussion
3.1 Correlated growth phase with chemotype
Streptomyces sp. MBT76 was previously identified as a
prolific producer of antibiotics, including two highly
methoxylated isocoumarins (Zhu et al. 2014b). To assess
the correlation between growth and antibiotic production,
MBT76 was grown in the liquid minimal medium (NMMP)
supplemented with 0.8 % (w/v) peptone, which has a
positive effect on the strain’s antibiotic producing capacity
(Zhu et al. 2014b). Samples for the determination of bio-
mass (dry weight) and antibiotic production (measured as
zones of inhibition against indicator strains) were collected
at 24 h time intervals until 120 h. A long lag phase of
growth was observed that covered the first 24 h, after
which the strain grew exponentially from 24–50 h. After
around 80 h, the culture entered a phase where biomass
decreased rapidly, most likely due to nutrient exhaustion
(Figure S1, A). Antibiotic activity against Bacillus subtilis
168 was not seen before 48 h (Figure S1, B), and the onset
of antibiotic production was seen after around 60 h of
growth. The largest inhibition zone (25 mm) was found for
supernatants obtained after 96 h, when cultures had already
entered the death phase.
NMR-based metabolomics was employed to correlate
bacterial growth and antimicrobial activity with the cor-
responding metabolic changes over time. At five time-
points, namely after 24, 48, 72, 96, and 120 h of inocula-
tion, the biomass of MBT76 was removed by centrifuga-
tion and the compounds present in the spent media were
extracted with ethyl acetate. The obtained metabolomes
were subjected to 1H NMR profiling and antimicrobial
assay against B. subtilis 168. The 1H NMR spectra varied
significantly in aromatic region d 6.0–8.0, and methoxyls
region d 3.45–4.25, with more complex proton signals as
time progressed (Fig. 1). Low levels of secondary
metabolites were produced before 48 h, while 72 h
appeared to be a turning point in terms of secondary
metabolites production. 96 h samples exhibited the most
complex metabolome as compared to the other groups,
coinciding with the highest antimicrobial activity against
B. subtilis. The compounds in the crude extracts were
elucidated with 1H NMR spectra and UPLC-ToF–MS
analysis (retention time, UV spectrum, and high resolution
mass). The metabolites included methoxylated iso-
coumarins (1–9) (Zhu et al. 2014b); red-pigmented unde-
cylprodiginine (10) and streptorubin B (11) (Cerden˜o et al.
2001); 1H-pyrrole-2-carboxamide (12) (Salem et al. 2014);
acetyltryptamine (13) (Mehdi et al. 2009); and fervenulin
(14) (Ruanpanun et al. 2011) (Fig. 2; Table 1). Among
these, the highly methoxylated compound 5,6,7,8-
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tetramethoxy-3-methyl-isocoumarin (9) has not been pre-
viously described. This novel molecule was determined
based on the similarity of its UV spectrum with those of
congeners 1–8 and a high resolution mass at m/z [M ? H]?
of 281.1039, calculated molecular formula C14H17O6
(Figure S2).
A plausible biosynthetic pathway (Fig. 3) is proposed
for isocoumarins 1–9. Although isocoumarin polyketides
are frequently reported in actinomycetes (Singh et al. 2013;
Zinad et al. 2011), the underlying genetic basis is poorly
understood. In view of the biosynthesis of the isocoumarin
backbone in fungi (Cochrane et al. 2016; Ishiuchi et al.
2012; Nakazawa et al. 2012; Zaehle et al. 2014), along with
dihydroisocoumarin assembly in the actinomycete Sac-
charopolyspora erythraea (Sun et al. 2012) and in sponge-
associated bacteria (Fisch et al. 2009), we tentatively pro-
pose that isocoumarin biosynthesis in Streptomyces sp.
MBT76 is executed by a type I iterative modular polyke-
tide synthase (PKS). Indeed, antiSMASH (Blin et al. 2013)
analysis of the genome of Streptomyces sp. MBT76 iden-
tified a gene cluster (icm, Table S1) that encodes the can-
didate PKS components. This contains the icmM gene that
encodes multiple catalytic domains including ketosynthase
(KS), acyl transferase (AT), dehydrase (DH), acyl carrier
24 h
48 h
72 h
96 h
120 h
Fig. 1 NMR profiling of Streptomyces sp. MBT76 harvested at 24-h
intervals. The 1H NMR spectra varied significantly in aromatic region
d 6.0–8.0, and methoxyls region d 3.45–4.25, with more complex
proton signals as time progressed. Assigned signals are numbered as
summarized in Table 1
O
OR4
R2
R1
R3
1, R1 = H, R2 = OH, R3 = H, R4 = OH
2, R1 = H, R2 = OCH3, R3 = H, R4 = OH
3, R1 = H, R2 = OCH3, R3 = H, R4 = OCH3
4, R1 = H, R2 = OH, R3 = OH, R4 = OH
6, R1 = H, R2 = OCH3, R3 = OH, R4 = OCH3
7, R1 = H, R2 = OCH3, R3 = OCH3, R4 = OCH3
8, R1 = OCH3, R2 = OCH3, R3 = H, R4 = OCH3
9, R1 = OCH3, R2 = OCH3, R3 = OCH3, R4 = OCH3
H
N
NH2
O
NH
N HN
O
10 NH
N HN
O
11
12
5, R1 = H, R2 = OCH3, R3 = OH, R4 = OH
14
H
N
H
N
O13
N
N N
N
N
O
O
Fig. 2 Secondary metabolites
produced by Streptomyces sp.
MBT76
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protein (ACP), which is likely responsible for the assembly
of the precursor 6,8-dihydroxy-3-methyl-isocoumarin (1).
This low-order isocoumarin could be further tailored by the
oxygenase encoded by icmF, and an O-methyltransferase
encoded by icmI.
The coexistence of compounds 7, 8, and 9 confirmed all
the non-bridged carbons (positions 5, 6, 7, and 8) in ben-
zene ring of isocoumarin could be methoxylated. This
suggests that MBT76 could produce more new iso-
coumarin-type intermediates than those that have been
elucidated here, like 4a, 4b, 6a, and 6b. Because both C-5
and C-7 of 1 could be hydroxylated, the substituted pattern
(5,6,8-trihydroxylation or 6,7,8-trihydroxylation) in
compounds 5 and 6 remained unclear. Some ambiguity
remained regarding the mono- and/or di- methylation pat-
terns in compounds 2, 5, and 6, as all four–OH groups on
ring A could be methylated. Further up-scale fermentation
followed by extensive phytochemical isolation is needed to
clarify ambiguities in structures of 2, 5, and 6, and to unveil
other new derivatives of isocoumarin family.
Multivariate data analysis (MVDA) was utilized to
correlate the antimicrobial activity with the responsible
signals in the 1H NMR spectra. An unsupervised MVDA,
principal component analysis (PCA) was first used to dis-
criminate samples, but in this way only the non-active 24 h
group was separated from other time-points (data not
Table 1 Spectral data assignments for the compounds displayed in Fig. 2
NO Compounds Characteristic1H NMR chemical shifts (ppm) Experimental mass (Da) UV kmax
(nm)
1 6,8-Dihydroxy-3-methyl-
isocoumarin
6.29 (d, J = 1.2, 1H); 6.24 (d, J = 2.4, 1H); 6.27 (d,
J = 2.4, 1H); 2.21 (d, J = 1.2, 3H)
193.0511 [M ? H]?; 215.0312
[M ? Na]?
244, 328
2 6-Methoxyl-8-hydroxy-3-
methyl-isocoumarin
207.0662 [M ? H]?; 229.0478
[M ? Na]?; 435.1053
[2 M ? Na]?
244, 326
3 6,8-Dimethoxyl-3-methyl-
isocoumarin
6.29 (d, J = 1.2, 1H); 6.47 (d, J = 2.4, 1H); 6.52 (d,
J = 2.4, 1H); 2.23 (d, J = 1.2, 3H); 3.89 (s, 3H);
3.90 (s, 3H)
221.0830 [M ? H]?; 243.0646
[M ? Na]?
244, 328
4 6,7,8-Trihydroxy-3-methyl-
isocoumarin
209.0441 [M ? H]? 244, 328
5 6-Methoxyl-7,8-dihydroxy-
3-methyl-isocoumarin
6.57 (d, J = 1.2, 1H); 6.38 (s, 1H); 3.75 (s, 3H); 2.26
(s, 3H)
223.0612 [M ? H]?; 245.0424
[M ? Na]?
244, 340
6 6,8-Dimethoxy-7-hydroxy-
methyl-isocoumarin
237.0779 [M ? H]?; 259.0593
[M ? Na]?; 495.1256
[2 M ? Na]?
240, 340
7 6,7,8-trimethoxy-3-methyl -
isocoumarin
6.35 (d, J = 1.2, 1H); 6.81 (s, 1H); 2.22 (d, J = 1.2);
3.95 (s, 3H); 3.83 (s, 3H); 3.90 (s, 3H)
251.0935 [M ? H]?; 273.0756
[M ? Na]?; 523.1596
[2 M ? Na]?
246, 336
8 5,6,8-Trimethoxy-3-methyl
-isocoumarin
6.55 (d, J = 1.2, 1H); 6.70 (s, 1H); 2.20 (d, J = 1.2,
3H); 3.76 (s, 3H); 4.00 (s); 3.95 (s, 3H)
251.0935 [M ? H]?; 273.0756
[M ? Na]?; 523.1596
[2 M ? Na]?
246, 336
9 5,6,7,8-Tetramethoxy-3-
methyl -isocoumarin
281.1039 [M ? H]?; 303.0861
[M ? Na]?; 583.1804
[2 M ? Na]?
240, 337
10 Undecylprodiginine 7.23 (s, 1H); 6.56 (s, 1H); 6.46 (dd, J = 4.8, 3.0, 1H);
6.39 (d, J = 4.8, 1H); 4.10 (s, 3H); 2.35 (t, J = 7.2,
2H)
394.2857 [M ? H]?
11 Streptorubin B 6.73 (s, 1H); 6.53 (s, 1H); 6.44 (dd, J = 4.8, 3.0, 1H);
6.41 (d, J = 4.8, 1H); 4.11 (s, 3H)
392.2692 [M ? H]?
12 1H-pyrrole-2-carboxamide 6.92 (dd, J = 2.4, 1.2, 1H); 6.81 (dd, J = 3.6, 1.2,
1H); 6.17 (t, J = 3.6, 2.4, 1H)
111.0562 [M ? H]?; 133.0372
[M ? Na]?
268
13 Acetyltryptamine 7.54 (dd, J = 7.8, 1.2, 1H); 7.31 (brd, J = 8.4, 1H);
7.70 (td, J = 7.8, 1.2, 1H); 6.99 (td, J = 7.8, 1.2,
1H); 7.05 (s, 1H); 3.45 (t, J = 7.2, 2H); 2.56 (t,
J = 7.2, 2H); 1.90 (s, 3H)
203.1211 [M ? H]?; 225.1011
[M ? Na]?
224, 282
14 Fervenulin 9.72 (s, 1H); 3.80 (s, 3H); 3.47 (s, 3H); 194.0705 [M ? H]?; 216.0482
[M ? Na]?
240, 344
Compound identification was based on 1H NMR, high resolution mass spectrometry, and UV absorption spectrum. Proton coupling constants
(J in Hz) are given in parentheses
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shown). As a next step to correlate metabolites detected in
the 1H NMR spectra with the bioactivity, orthogonal pro-
jection to latent structures (OPLS) was applied to the data
using Y-variable of antimicrobial activity (inhibition per-
centage), allowing the removal of spectral X-variables
unrelated to the sample classes chosen and filtration of the
biomarkers from the biological varieties (Trygg and Wold
2003). The regression has been validated using cross val-
idation analysis of variance (CV-ANOVA), with a P value
\0.001. Separation of all the harvesting times could be
observed in the OPLS score plot, with the active group (72,
96, and 120 h) clustered in the positive side along the
OPLS1 axis (Fig. 4a). The S-plot presented the signals
contributable to the discrimination among the samples with
diversified antibacterial activities. The major signals
responsible for the bioactivity were assigned as 6,7,8-tri-
methoxyl-3-methyl-isocoumarin (7), 5,7,8-trimethoxyl-3-
methyl-isocoumarin (8), and acetyltryptamine (13)
SCoA
O
+ OO
HO SCoA
4 x O
O
O
O
O
ACP
OOH
HO
O
ACP
OOH
HO
OH
ACP
O
OO
O
PKS bioassembly
post-PKS modification
O
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Fig. 3 Biosynthetic pathway of isocoumarins produced by Strepto-
myces sp. MBT76. a Organization of the type I iterative PKS gene
cluster (icm) in Streptomyces sp. MBT76 (Table S1). b Proposed
biosynthetic route to highly methoxylated isocoumarins 7–9. The
modular non-reducing PKS gene icmM was iteratively used to
assemble the basic backbone 6,8-dihydroxy-3-methyl-isocoumarin
(1), which was further furnished into a range of methoxylated
isocoumarins by the oxidoreductase icmF and the methyltransferase
icmI in the post-PKS stage
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(Figs. 4, b, c). The antibiotic activity may at least in part be
attributed to acetyltryptamine (13), which was previously
reported to have broad-spectrum antibiotic properties
(Mehdi et al. 2009). To test whether methoxylation helped
increase the antimicrobial activity of isocoumarins, we
isolated four major isocoumarins (1, 3, 7, and 8) with low
and/or high level of methoxylation. Comparison of the
antimicrobial activity of these compounds was performed
by agar diffusion assay, against the Gram-positive B.
subtilis 168 and the Gram-negative E. coli K12 (Fig-
ure S3). The tri-methoxylated isocoumarins 7 and 8
exhibited pronounced inhibition of growth of B. subtilis,
while compounds 1 and 3 only gave negligible inhibition
zones. The same trend was also observed for inhibition
against E. coli, though the bioactivity of the compounds
against this strain was much lower than against B. subtilis.
This result validated the OPLS analysis that attributed tri-
methoxylated isocoumarins 7 and 8 rather than non-
methoxylated precursor 1 as the discriminators for the
higher bioactivity at 96 h and 120 h. Based on this obser-
vation, we anticipated that the new compound 5,6,7,8-te-
tramethoxyl-3-methyl-isocoumarin (9) should have even
better antimicrobial property than 7 and 8, but its purifi-
cation failed due to intrinsic low abundance (Figure S2).
To correlate harvesting time to specific metabolites, we
used time as the Y-variable in the OPLS analysis, resulting
in a similar separation pattern of the five time-points
along OPLS1 (Figure S4, a). The major discriminators for
96 h and 120 h groups were the same to those for activity
as Y-variable OPLS analysis (Figure S4, b). Taken toge-
ther, the dynamic 1H NMR profiling and MVDA
demonstrated the time-dependent biosynthesis of antibi-
otics (1–14) produced by Streptomyces sp. MBT76. This
strain began to produce precursor 6,8-dihydroxy-3-
methyl-isocoumarin (1) at 48 h, whose methoxylation into
2–9 at all the non-bridged carbons of the benzene ring
occurred after 72 h, whereby the highly methoxylated
isocoumarins 7 and 8 peaked at 96 h. Prodiginines (10 and
11) were observed throughout growth, which was reflec-
ted by the abundant by-product 1H-pyrrole-2-carboxam-
ide (12) initiated at 48 h and the red appearance of the
culture broth (Cerden˜o et al. 2001). The antibiotics
acetyltryptamine (13) and fervenulin (14) were particu-
larly produced at later time-points.
acetyltryptamine
methoxylation
isocoumarins
isocoumarins
1H-pyrrole-2-carboxamide
A
B C
Fig. 4 Supervised multivariate data analysis of the NMR spectra.
a orthogonal projection to latent structures (OPLS) score plot showed
separation of different time-points along OPLS1, and b the corre-
sponding S-plot highlighted the compounds responsible for better
activity in latter time points (96 and 120 h). c These compounds were
identified as acetyltryptamine (13), and methoxylated isocoumarins (7
and 8) as annotated. Y value in OPLS analysis was antimicrobial
bioactivity against Bacillus subtilis 168
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3.2 Metabolomics-driven biotransformation
of phenylpropanoids
Inspired by the post-PKS methoxylation of 6,8-dihydroxy-
3-methyl-isocoumarin (1, Fig. 3), we then wanted to see
what would happen in a biotransformation experiment
whereby the isoflavone genistein was fed to cultures of
Streptomyces sp. MBT76. Genistein and other isoflavones
contain a similar fused benzopyranone moiety as iso-
coumarins and the same meta-hydroxylation on ring A. In
accordance with the dynamic metabolism of isocoumarins
as shown by the NMR-based metabolomics, genistein was
fed to MBT76 culture broth at 48 h, i.e. in the ‘late
exponential’ growth phase, and incubation was allowed to
continue for another 72 h. The ethyl acetate extract was
then subjected to NMR and TLC analysis and compared to
control samples. To identify genistein-derived biotrans-
formation products, we performed NMR-guided chro-
matographic separation (Wu et al. 2015a) by tracking the
downfield aromatic singlet (H-2 around d 8.0) that is
characteristic of isoflavones in the 1H NMR spectrum. The
purified products were subsequently subjected to NMR for
structure elucidation. The 1H NMR (methanol-d4,
600 MHz) spectrum of compound 16 presented two
methoxyls, besides two meta-coupled aromatic doublets,
which allowed identification of one of the genistein-
derived biotransformation products as 40-hydroxy-5,7-
dimethoxy-isoflavone (16) (Miyazawa et al. 2006). In
comparison, the major discrepancy in the 1H NMR spec-
trum of compound 15 was a single O-CH3, which indicated
that a mono-methylation had occurred in the ring A. When
DMSO-d6 was used as solvent, the downfield-shifted
exchangeable hydroxyl d 11.5–13.5 that originates from
the intramolecular hydrogen bonding with ketone (C-4)
had disappeared, which was indicative of methylation at
the 5-OH. Thus, compound 15 was identified as 40,7-di-
hydroxy-5-methoxy-isoflavone. The 1H NMR spectrum of
compound 17 identified three methoxyls at d 3.94, 4.02,
and 3.85, together with one uncoupled singlet at d 6.68,
which indicated tri-methoxylation at ring A. The possi-
bility of methylation on ring B (40-OH) was ruled out by
HMBC and HSQC NMR. Furthermore, the two correla-
tions H-6/5-OCH3 and H-6/7-OCH3 in the
1H–1H NOESY
spectrum confirmed that compound 17 was 40-hydroxy-
5,7,8-trimethoxy-isoflavone. Compound 18 shared the
same substitution mode with 17 in ring A because of one
uncoupled singlet at d 6.48, but it presented two methoxyls
in the 1H NMR spectrum. One methyl was located at 8–OH
based on the HMBC correlation from 8-OCH3 (d 3.86) to
C–8 (dC 134.4). The other methyl was located at the 5-OH
rather than at the 7-OH because no signal was observed in
the range of d 11.5–13.5 when measured in DMSO-d6.
Taken together, genistein underwent exactly the same
methylation pattern of isocoumarin 1, as summarized in
Fig. 5. In consideration of the structural similarity
between isocoumarin 1 and genistein, it is conceivable
that the same O-methyltransferase (icmI) is involved in
the methylation of both substrates. Interestingly, this O-
methyltransferase methylated isoflavone at all the three
hydroxyl groups on ring A, but not at the single p-hy-
droxyl group on ring B.
Motivated by the biotransformation of genistein, we also
investigated whether the structurally related flavone api-
genin and the dihydroflavonol naringenin could also be
methoxylated. Unexpectedly, both apigenin and naringenin
resisted biotransformation by MBT76, as evidenced by
TLC and NMR analysis. The linkage pattern of the ben-
zene ring B on chromone (at either C-2 or C-3) might
influence the efficiency of methylation. From the per-
spective of biosynthesis it is interesting to note that in
plants, ring B of flavonoids originates from cinnamic acid
(Park et al. 2009). Therefore, we further tested whether
hydroxycinnamic acids could be methylated. Six com-
mercially available congeners, including cinnamic acid, o,
m, p- coumaric acid, caffeic acid, and ferulic acid, were
fed to the Streptomyces sp. MBT76. The corresponding
biotransformation products were identified in mixture
through 1H NMR profiling and confirmed by UPLC-ToF–
MS analysis. Amidation at the carboxyl group was the
exclusive modification for all the (hydroxyl)cinnamic
acids, with the exception of ferulic acid that could also be
methylated at the 4-OH group (Figure S5). Unlike the
situation of isocoumarins, where activity increases on
methylation, methylated isoflavones had lower bioactivity
than the unmethylated precursors. As shown in Figure S3,
genistein showed highest antibiotic activity against both
B. subtilis and E. coli, while tri-methoxylated biotrans-
formation product 19 failed to inhibit growth of the
indicator strains. This observation was in accordance with
previous results that the free phenolic OH groups of fla-
vonoids are crucial for potent antimicrobial activity
against Gram-positive and Gram-negative bacteria
(Thongnest et al. 2013).
The in vitro biochemical reaction may in some cases be
more advantageous than in vivo biotransformation for
functional characterization of enzymes, e.g. due to limited
uptake of the substrate, or because substrates may have an
effect on overall gene expression of the various biosyn-
thetic pathways. While the expected in vivo methylation of
apigenin, naringenin, and most (hydroxyl)cinnamic acids
was not observed, the potential promiscuity of methyl-
transferase IcmI suggested by post-PKS modification of
isocoumarin (Fig. 3) and biotransformation of genistein
(Fig. 5) is intriguing and may allow the methylation of a
broader range of chemical skeletons. This is currently
being investigated in our laboratory.
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4 Conclusion
The growth phase has a major influence on the production
of secondary metabolites in Streptomyces sp. MBT76.
Four days of incubation was optimal to accumulate
antimicrobial compounds identified as 6,7,8-trimethoxyl-3-
methyl-isocoumarin (7), 5,7,8-trimethoxyl-3-methyl-iso-
coumarin (8), 5,6,7,8-tetramethoxyl-3-methyl-isocoumarin
(9), and acetyltryptamine (13). However, production of 6,8-
dihydroxyl-3-methyl-isocoumarin (1) was optimal after
two days of incubation. NMR spectroscopy in conjugation
with multivariate data analysis effectively identified spe-
cialized metabolites in the crude extract of MBT76, but
also highlighted differences between the metabolomes at
the different time-points. The methodology applied in this
work should be useful for scientists who seek to identify
the optimal fermentation time to harvest desirable bioactive
compounds from cultures of in principle any microorgan-
ism that produces promising bioactive molecules, such as
those with potential industrial or medical application.
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